Mr. John Hennessy:

There were nine products that I mentioned earlier that have been considered and have been through the formal process of assessment by the drugs committee and the leadership team. They all represent additional resourcing requirements, including in the current year. That resourcing is not in place in the 2017 HSE service plan, and additional resourcing will have to be found in order to proceed with implementation.